Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223749 · ClinicalTrials.gov registry record
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
A clinical trial of COPD (Chronic Obstructive Pulmonary Disease), sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT07223749 is a study of COPD (Chronic Obstructive Pulmonary Disease) that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 500 participants, below the 679-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (26% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07223749, a study of COPD (Chronic Obstructive Pulmonary Disease), is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
Under-diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is prevalent, with an estimated 75% of adults suffering from COPD in the US, without clinical recognition. Often, the first diagnosis of COPD comes with a flare or exacerbation. In one study, 34% of patients were first diagnosed during hospitalization for an exacerbation, an event associated with a 1-year mortality rate of 26%. When COPD is finally diagnosed, it is often in the late stages, with an average lung function of 50% of normal. Conversely, COPD can be over-diagnosed, defined as symptoms in an individual without airflow obstruction. Over-diagnosed people have significantly higher rates of hospitalization, ER visits, and ambulatory care visits because individuals are treated for a disorder they don't have and are not being treated for the disorder they do have. Lack of diagnostic clarity places patients at risk of medication complications without potential benefit. Conversely, failure to diagnose preempts the benefits of therapy. To date, no reliable solution has been found to address this problem.
Conditions Studied
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-08-22 |
| Est. Completion | 2026-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07223749
The ClinicalTrials.gov registry entry for NCT07223749 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 679-participant average among 9 other COPD (Chronic Obstructive Pulmonary Disease) trials with a reported enrollment target (26% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with COPD (Chronic Obstructive Pulmonary Disease) appearing as the primary indexed condition, and to 0 interventions.
NCT07223749 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT07223749 about?
NCT07223749 is a clinical study titled "Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm". Under-diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is prevalent, with an estimated 75% of adults suffering from COPD in the US, without clinical recognition. Often, the first diagnosis of COPD comes with a flare or exacerbation. In one study, 34% of patients were first diagnosed during ...
What is the current status of trial NCT07223749?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2025-08-22. Estimated completion is 2026-12-30.
What conditions does trial NCT07223749 study?
This clinical trial studies the following conditions: COPD (Chronic Obstructive Pulmonary Disease).
Who is sponsoring clinical trial NCT07223749?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07223749 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD (Chronic Obstructive Pulmonary Disease)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
RECRUITING
-
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
Photon-counting CT in Chest Imaging
RECRUITING · NA
-
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
RECRUITING · NA
-
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
RECRUITING · Phase 4
-
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.